This finding falls in line with the hypothesis proposed by Eisenmann et al. identifying RSK activity as a crucial mediator of melanoma cell survival driven by the constitutively activated MAPK signalling pathway [27]. The gene discussed is RPS6KA1; the disease is melanoma.